How the Pharmaceutical Industry is Tackling Scope 3 Emissions

The Energize supply chain decarbonization program brings together leading pharmaceutical companies to collaborate on reducing their Scope 3 emissions and mitigating the overall environmental impact of the pharmaceutical industry. By working with Schneider Electric and other leading pharmaceutical companies, Energize aims to assist pharmaceutical suppliers in adopting renewable energy by providing education and removing market barriers.

In this video, representatives from two pharmaceutical companies participating in this program, GSK and Novartis, talk about the goal of the program and the potential for this model to be scaled to other sectors.

Previous Video
Experts’ Update on UK’s Re-Opened Climate Change Agreement
Experts’ Update on UK’s Re-Opened Climate Change Agreement

The CCA scheme on voluntary climate agreements between UK businesses and the government has re-opened for n...

Next Video
A Look Back on 2021 CDP Outcomes and Look Ahead for 2022
A Look Back on 2021 CDP Outcomes and Look Ahead for 2022

Another record year for CDP as over 13,000 organizations disclosed climate change, water security and defor...

Get Exclusive First Access to New Content Each Month

SIGN UP